Last month, NBSO Texas attended two prominent events within Houston’s rapidly evolving life sciences ecosystem. Both gatherings reflect the region’s continued development as an international center for medical innovation and provide insight into opportunities for international companies, including those from the Netherlands.
Opening of Therapeutic Labs @ Texas Medical Center
During the “Bubbles & Beakers” event, a new facility was officially launched at the Texas Medical Center (TMC): Therapeutic Labs @ TMC. The facility is designed to support collaboration and accelerate the development of new therapeutic solutions.
This expansion reflects TMC’s broader strategy to strengthen its capabilities beyond clinical care and digital health, with an increasing focus on biotechnology and therapeutics. The event brought together researchers, entrepreneurs, and industry stakeholders, highlighting the development of a more integrated innovation ecosystem where research, clinical validation, and commercialization are closely connected.
Industrial Translation Day at the Houston Methodist Rice Digital Health Institute
NBSO Texas also participated in the Industrial Translation Day, hosted by the Houston Methodist Rice Digital Health Institute, a collaboration between Houston Methodist and Rice University.
The event focused on collaboration between industry, researchers, and startups in digital health. A number of international companies presented current challenges through a “reverse pitch” format, inviting participants to respond with potential solutions. Key themes included artificial intelligence, predictive healthcare, and data-driven approaches to care.
Dutch participation: Clear.bio
Dutch company Clear.bio was among the participants. Co-founder Menno van der Eijk joined a startup panel, sharing perspectives on data-driven healthcare innovation.
Clear.bio focuses on personalized diabetes care by combining continuous glucose monitoring artificial intelligence, and tailored nutrition advice. By translation real-time biological data into actionable insights, the company aims to support individuals with type 2 diabetes in better understanding and managing their condition.
Participation in the panel facilitated exchanges with industry representatives, clinicians, and other innovators, and contributed to the company’s ongoing network development in the United States.
Relevance for Dutch companies
Together, these events illustrate Houston’s development into a more integrated life sciences hub, characterized by strong connections between academic research, healthcare institutions, startups, and global industry players.
For Dutch companies active in life sciences, medtech, and digital health, this environment offers opportunities for collaboration, market entry, and the further development and validation of innovations.
By attending key events such as these, NBSO Texas remains closely connected to developments within the regional ecosystem. This enables the office to support Dutch companies in exploring opportunities and establishing partnerships in Texas and the broader U.S. market.
